About Us

Infectious Diseases Hub aims to provide up-to-date, essential research and information on all aspects of virology and microbiology, from bench to bedside.

Microbiology has inevitably been impacted by the genomic revolution, and virology and genomic research have been closely linked for many years. It is now possible to determine viral-host interactions during infection in an unprecedented level of detail, providing a complete catalogue of potential antiviral targets for investigation.

Additionally, the availability of both human and microbial genome sequences allows scientists to better understand exactly how microbes interact with the hosts they infect, and how an individual’s genetic make-up influences their susceptibility to pathogens.

ID Hub aims to deliver the news, peer-reviewed articles, interviews and exclusive comment from KOLs on the areas that interest you, as well as providing easily-digestible multi-media content and a disease tracker to allow you to follow the latest disease outbreaks and related research.

Join our free online knowledge hub to be the first to know what’s impacting in your area of interest.

Coverage includes:

  • The molecular basis of microbial and viral diseases
  • Microbe–host and virus–host interactions
  • Overviews highlighting optimal therapeutic and diagnostic approaches, along with potential future options
  • The use of microbes in the treatment of disease and genetic engineering
  • The use of viral vectors in gene therapy and functional genomics
  • Summaries evaluating newly approved antimicrobial and antiviral agents
  • Vaccine development and the prevention of viral diseases
  • Adverse events and drug safety
  • Pharmacoeconomics and cost–benefit issues
  • New and re-emerging microbes and viruses
  • DNA microarrays for the identification of new viruses
  • Microbial genome research, and the implications to higher organisms
  • Microbes and cancer
  • Epidemiologic studies and trends
  • The problem of drug resistance, and potential methods to overcome this
  • Defense against use in bioterrorism.

The Team

Martha Powell

Editor

Email: m.powell@id-hub.com

LeelaLeela Ripton

Head of Marketing

Email: l.ripton@futuremedicine.com

Regular Contributers

Hannah Makin

Commisioning Editor, Future Science Group (London, UK)

Sharon Salt

Production Editor, Future Science Group (London, UK)

Julie Kaiser

Postgraduate Student, University of Western Ontario (Ontario, Canada)

Kelvin Adu-darko

Production Editor, Future Science Group (London, UK)